• LAST PRICE
    0.2756
  • TODAY'S CHANGE (%)
    Trending Down-0.0173 (-5.9065%)
  • Bid / Lots
    0.2757/ 3
  • Ask / Lots
    0.2800/ 1
  • Open / Previous Close
    0.2980 / 0.2929
  • Day Range
    Low 0.2740
    High 0.2980
  • 52 Week Range
    Low 0.2500
    High 5.2750
  • Volume
    192,452
    above average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Monday's close: 0.2929
TimeVolumeFOXO
09:32 ET38590.295
09:34 ET78330.294899
09:36 ET161350.274
09:38 ET12830.2877
09:43 ET9980.288
09:48 ET3000.29
09:52 ET1090.295
09:54 ET22000.29
09:56 ET52210.295
10:01 ET55000.290001
10:08 ET91910.29
10:17 ET40000.29
10:21 ET156210.298
10:24 ET3000.29799
10:33 ET13000.29405
10:42 ET4080.29405
10:51 ET19500.294
11:02 ET3800.293899
11:04 ET3500.2939
11:08 ET3500.2938
11:13 ET27000.2925
11:15 ET3000.29
11:18 ET7000.2914
11:20 ET94000.2938
11:22 ET1000.29175
11:40 ET41650.2843
12:00 ET1000.2811
12:07 ET150000.28
12:09 ET382460.2745
12:14 ET2000.27955
12:23 ET35080.2746
12:25 ET270000.275
12:36 ET19910.2756
Data delayed at least 15 minutes.
No documents available
0 New Today
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesFOXO
Foxo Technologies Inc
2.6M
0.0x
---
United StatesVSST
Voice Assist Inc
2.2M
-0.2x
---
United StatesPVSP
Pervasip Corp
1.6M
-0.8x
---
United StatesATHC
Accelerated Technologies Holding Corp
65.2K
0.0x
---
United StatesBFCH
Bitfrontier Capital Holdings Inc
2.3M
0.0x
---
United StatesIGEN
IGEN Networks Corp
970.4K
-0.4x
---
As of 2024-04-23

Company Information

FOXO Technologies Inc. is a biotechnology company. The Company is focused on commercializing longevity science through products and services that serve the life insurance industry. Its epigenetic technology applies artificial intelligence (AI) to deoxyribonucleic acid (DNA) methylation to identify molecular biomarkers of human health and aging. The Company operates through two segments: FOXO Labs and FOXO Life. FOXO Labs is commercializing epigenetic biomarker technology to be used for mortality underwriting and risk classification in the global life insurance industry. Its biomarker technology enables the adoption of new saliva-based health and wellness biomarker solutions for underwriting and risk assessment. FOXO Life is redefining the relationship between consumers and insurers by combining life insurance with healthy longevity. FOXO Life seeks to transform the value proposition of the life insurance carrier from a provider of mortality risk protection products.

Contact Information

Headquarters
729 Washington Ave. N, Suite 600MINNEAPOLIS, MN, United States 55401
Phone
612-562-9447
Fax
302-636-5454

Executives

Independent Director
Bret Barnes
Interim Chief Executive Officer, Director
Mark White
Interim Chief Financial Officer
Martin Ward
Independent Director
Francis Dewolf
Independent Director
Murdoc Khaleghi

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$2.6M
Revenue (TTM)
$453.0K
Shares Outstanding
8.9M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
---
EPS
$-25.90
Book Value
$2.44
P/E Ratio
0.0x
Price/Sales (TTM)
5.8
Price/Cash Flow (TTM)
---
Operating Margin
-9,051.44%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.